Articles

Diabetes mellitus continues to grow as a global healthcare problem and is associated with significant microvascular and macrovascular complications. 

We’ve all heard by now that people with diabetes are at greater risk of serious complications from the novel coronavirus COVID-19. Research into the connection and how to best treat patients with diabetes and COVID-19 is underway, and we will be sharing the studies with you as they become available. …

Researchers successfully converted human cells to produce insulin, which reduced the blood sugar of mice dramatically after being infused. 

Even patients with diabetes who have insurance are experiencing more financial hardship than those without diabetes.   

Glucocorticoids (GC) may expose patients to the risk of diabetes, particularly with long term use.

by Guest Writer Richard Purcell
More than 100 million U.S. adults are now living with diabetes or prediabetes, according to the Centers for Disease Control and Prevention.1 This epidemic requires new healthcare models to deliver optimal, patient-focused, guideline-directed care to improve outcomes and reduce costs. The establishment of a new multispecialty Managed Services Organization (MSO) in Arizona spotlights the numerous benefits, to patients and providers alike, of providing end-to-end healthcare services and disease management solutions for complex diabetes.

Flu season is upon us; what does that mean for patients with type 2 diabetes?

Does your ancestral origin determine your risk of developing type 1 diabetes?

A new study revealed that plasma aspartic acid and asparagine levels predict development of prediabetes; histidine plasma levels proved protective of prediabetes risk.  

Preserving beta cell function will maintain glucose homeostasis and may prevent diabetes.